Stocks and Investing Stocks and Investing
Fri, March 12, 2021
Thu, March 11, 2021
Wed, March 10, 2021
Tue, March 9, 2021
Mon, March 8, 2021

Ed Arce Maintained (AKBA) at Strong Buy with Decreased Target to $6 on, Mar 8th, 2021


Published on 2024-10-27 15:52:29 - WOPRAI
  Print publication without navigation


Ed Arce of HC Wainwright & Co., Maintained "Akebia Therapeutics, Inc." (AKBA) at Strong Buy with Decreased Target from $9 to $6 on, Mar 8th, 2021.

Ed has made no other calls on AKBA in the last 4 months.



There is 1 other peer that has a rating on AKBA. Out of the 1 peers that are also analyzing AKBA, 0 agree with Ed's Rating of Hold.



This is the rating of the analyst that currently disagrees with Ed


  • Eric Joseph of "JP Morgan" Downgraded from Hold to Sell on, Friday, January 29th, 2021